Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features-Reference-Cited by-同舟云学术

Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features

Published:2014-09-24 Issue:5 Volume:16 Page:
ISSN:1478-6354
Container-title:Arthritis Research & Therapy
language:en
Short-container-title:Arthritis Res Ther

Author:

Cipriani Paola,Di Benedetto Paola,Ruscitti Piero,Campese Antonio Francesco,Liakouli Vasiliki,Carubbi Francesco,Pantano Ilenia,Berardicurt Onorina,Screpanti Isabella,Giacomelli Roberto

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

http://link.springer.com/content/pdf/10.1186/s13075-014-0442-z.pdf

Reference44 articles.

1. Varga J, Abraham D: Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest. 2007, 117: 557-567. 10.1172/JCI31139.

2. LeRoy EC: Systemic sclerosis. A vascular perspective. Rheum Dis Clin North Am. 1996, 22: 675-694. 10.1016/S0889-857X(05)70295-7.

3. Loeys BL, Gerber EE, Riegert-Johnson D, Iqbal S, Whiteman P, McConnell V, Chillakuri CR, Macaya D, Coucke PJ, De Paepe A, Judge DP, Wigley F, Davis EC, Mardon HJ, Handford P, Keene DR, Sakai LY, Dietz HC: Mutations in fibrillin-1 cause congenital scleroderma: stiff skin syndrome. Sci Transl Med. 2010, 2: 23ra20-10.1126/scitranslmed.3000488.

4. Dulauroy S, Di Carlo SE, Langa F, Eberl G, Peduto L: Lineage tracing and genetic ablation of ADAM12(+) perivascular cells identify a major source of profibrotic cells during acute tissue injury. Nat Med. 2012, 18: 1262-1270. 10.1038/nm.2848.

5. Cipriani P, Carubbi F, Liakouli V, Marrelli A, Perricone C, Perricone R, Alesse E, Giacomelli R: Stem cells in autoimmune diseases: implications for pathogenesis and future trends in therapy. Autoimmun Rev. 2013, 12: 709-716. 10.1016/j.autrev.2012.10.004.

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing Mesenchymal Stem Cells for Regenerative Medicine: Influence of Diabetes, Obesity, Autoimmune, and Inflammatory Conditions on Therapeutic Efficacy: A Review;Medical Science Monitor;2024-07-23

2. TGF-β1 Drives Integrin-Dependent Pericyte Migration and Microvascular Destabilization in Fibrotic Disease;The American Journal of Pathology;2024-07

3. Ocular Involvement in Systemic Sclerosis: Updated Review and New Insights on Microvascular Impairment;Ocular Immunology and Inflammation;2024-03-11

4. Mesenchymal stem cell-based therapy for autoimmune-related fibrotic skin diseases—systemic sclerosis and sclerodermatous graft-versus-host disease;Stem Cell Research & Therapy;2023-12-18

5. Pathogenesis of vasculopathy in systemic sclerosis and its contribution to fibrosis;Current Opinion in Rheumatology;2023-07-24